We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Ingestible X-Ray Capsule Supports Colorectal Cancer Screening

By HospiMedica International staff writers
Posted on 01 Sep 2016
An innovative ingestible capsule system utilizes ultra-low dose X-ray emission for preparation-free colorectal cancer screening.

The Check-Cap capsule is designed to ingested and left to do its work as the patient goes about his or her normal day, with the only requirement being that patient takes regular small amounts of a standard contrast agent with meals. More...
As the capsule moves through the gastrointestinal (GI) tract, it emits radiation equivalent to that of a standard chest X-ray in order to scan the inside of the colon. The information gathered is transmitted to a device on the patient’s back via wireless communication technologies.

The low-dose X-ray radar scans are used to create standard and three-dimensional (3D) images of the colon, using 360-degree angular scans that “see” through intestinal content. The data is later analyzed by a physician. If nothing is detected, the patient does not require a standard colonoscopy; however, if the Check-Cap device does reveal polyps, a therapeutic colonoscopy would be prescribed. The Check-Cap capsule is under development by Check-Cap (Isfiya, Israel), and is currently not cleared for marketing in any jurisdiction.

“Check-Cap's prep-free, non-invasive technology meets the real need for colon cancer screening that's easy for patients. Patients are often hesitant to undergo colonoscopy due to the preparation, sedation, general discomfort and potential risks,” said Professor Oscar Lebwohl, MD, of Columbia University (New York, NY, USA). “If further studies demonstrate that Check-Cap is an accurate screening modality for colon cancer and polyps, then the Check-Cap system will be a viable testing alternative, allowing the screening of patients in greater numbers and the use of fewer resources compared with CTC and Colonoscopy.”

Colorectal cancer is the second leading cause of cancer death in the United State, with an estimated 134,000 diagnoses and 49,000 deaths in 2016. Despite compelling evidence that screening can detect colorectal cancer and precancerous polyps, nearly one-third of the recommended adult population has never been screened. The Check-Cap system was designed to improve the patient experience by addressing many frequently cited barriers to test completion, including laxative bowel preparation, invasiveness, stool handling, and sedation.

Related Links:
Check-Cap


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Syringe Pump
SP50 Series
Immobilization System
Cranial 4Pi Immobilization
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Artificial intelligence (AI) standalone performance and reader performance with versus without AI assistance. (A) Receiver operating characteristics (ROC) curve for AI standalone performance in the US dataset (AUC 0.899, 95% CI 0.858 to 0.939). (B) ROC curve for AI standalone performance in the Korean dataset (AUC 0.963, 95% CI 0.946 to 0.975). (C) Pooled reader ROC without (AUC 0.718) versus with (AUC 0.852) AI assistance in the Korean dataset; P<0.001. AUC, area under the receiver operating characteristics curve. (Leonard Sunwoo et al., Journal of NeuroInterventional Surgery (2026). DOI: 10.1136/jnis-2026-025339)

AI Improves Non-Contrast CT Interpretation for Time-Sensitive Stroke Assessment

Acute ischemic stroke occurs when a blood vessel in the brain becomes blocked, requiring rapid diagnosis to enable timely reperfusion therapy. Emergency departments often use computed tomography angiography... Read more

Critical Care

view channel
Image: Anatomically guided sonography for trauma assessment includes a mixed reality headset (e.g., top left). Example views show virtual augmentation overlays for anatomy registration and ultrasound probe guidance on a test surrogate. The anatomical display is customized based on the organ or region being targeted with the ultrasound probe. (Robert S. Armiger, Anna E. Knight, Catherine M. Carneal, et al. Journal of Medical Imaging (2026). DOI: 10.1117/1.jmi.13.4.045001)

Anatomical Guidance System Improves Trauma Ultrasound Acquisition by Novice Users

Focused assessment with sonography for trauma (FAST) helps clinicians detect free fluid and signs of internal bleeding in injured patients, but obtaining reliable images can be difficult for inexperienced operators.... Read more

Surgical Techniques

view channel
Image: MIT researchers have developed a handheld device capable of gently collecting living cells from specific locations to test for ovarian and many other types of cancer. (Photo courtesy of Kripa Varanasi, et al)

Handheld Device Improves Targeted Cell Collection for Early Ovarian Cancer Assessment

High-grade serous ovarian cancer is the most common form of ovarian cancer, and many cases are thought to originate in the fallopian tubes. Because precursor lesions can be microscopic, they are difficult... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.